Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]MNI-968 PET in Healthy Volunteers
NCT03082768Phase 1Completed
- Sponsor
- Molecular NeuroImaging
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Molecular NeuroImaging. Primary endpoint: Regional [18F]MNI-968 binding/uptake expressed in SUV at 1 year. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT03082768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082768.